Johann Foloppe

666 total citations
29 papers, 478 citations indexed

About

Johann Foloppe is a scholar working on Genetics, Oncology and Biotechnology. According to data from OpenAlex, Johann Foloppe has authored 29 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Genetics, 16 papers in Oncology and 10 papers in Biotechnology. Recurrent topics in Johann Foloppe's work include Virus-based gene therapy research (28 papers), CAR-T cell therapy research (16 papers) and Cancer Research and Treatments (10 papers). Johann Foloppe is often cited by papers focused on Virus-based gene therapy research (28 papers), CAR-T cell therapy research (16 papers) and Cancer Research and Treatments (10 papers). Johann Foloppe collaborates with scholars based in France, United Kingdom and Switzerland. Johann Foloppe's co-authors include Philippe Erbs, Pascale Cordier, Annie Findeli, Éric Quéméneur, Jacqueline Kintz, Y. Schlesinger, Chantal Hoffmann, Jean‐Marc Balloul, Laetitia Fend and Marie‐Caroline Dieu‐Nosjean and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Johann Foloppe

26 papers receiving 471 citations

Peers

Countries citing papers authored by Johann Foloppe

Since Specialization

Citations

This map shows the geographic impact of Johann Foloppe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johann Foloppe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johann Foloppe more than expected).

Fields of papers citing papers by Johann Foloppe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johann Foloppe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johann Foloppe. The network helps show where Johann Foloppe may publish in the future.

Co-authorship network of co-authors of Johann Foloppe

This figure shows the co-authorship network connecting the top 25 collaborators of Johann Foloppe. A scholar is included among the top collaborators of Johann Foloppe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johann Foloppe. Johann Foloppe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Les virus oncolytiques : acteurs et vecteurs de protéines thérapeutiques contre les tumeurs 2023 ·médecine/sciences ·(unknown), Johann Foloppe	0
2	Oncolytic virotherapy with intratumoral injection of vaccinia virus TG6002 and 5-fluorocytosine administration in dogs with malignant tumors 2023 ·Molecular Therapy — Oncolytics ·(unknown), Eve Laloy, (unknown), Murielle Gantzer, (unknown), (unknown), (unknown), Johann Foloppe, Jean‐Marc Balloul, Christelle Machon, Jérôme Guitton, Dominique Tierny, Bernard Klonjkowski, Éric Quéméneur, Christelle Maurey, Philippe Erbs	6
3	Harnessing the power of oncolytic virotherapy and tertiary lymphoid structures to amplify antitumor immune responses in cancer patients 2023 ·Seminars in Immunology ·(unknown), Johann Foloppe, Marie‐Caroline Dieu‐Nosjean	14
4	Abstract 3567: Comprehensive preclinical studies of BT-001: An oncolytic vaccinia virus armed with Treg-depleting @CTLA4 and GM-CSF 2022 ·Cancer Research ·Jean‐Baptiste Marchand, Monika Semmrich, (unknown), Matilda Rehn, Laetitia Fend, (unknown), Nathalie Silvestre, (unknown), (unknown), Jules Deforges, (unknown), Linda Mårtensson, Johann Foloppe, Ingrid Teige, Björn Frendéus, Éric Quéméneur	1
5	Safety, biodistribution and viral shedding of oncolytic vaccinia virus TG6002 administered intravenously in healthy beagle dogs 2021 ·Scientific Reports ·(unknown), Murielle Gantzer, (unknown), Johann Foloppe, Bernard Klonjkowski, Christelle Maurey, Éric Quéméneur, Philippe Erbs	7
6	Fluorescent Tagged Vaccinia Virus Genome Allows Rapid and Efficient Measurement of Oncolytic Potential and Discovery of Oncolytic Modulators 2020 ·Biomedicines ·Franck Gallardo, D Schmitt, (unknown), (unknown), Nathalie Silvestre, Annie Findeli, Johann Foloppe, (unknown), (unknown), (unknown), Renaud Morin, Jean‐Michel Lagarde, Kerstin Bystricky, Stéphane Bertagnoli, Philippe Erbs	10
7	High Oncolytic Activity of a Double-Deleted Vaccinia Virus Copenhagen Strain against Malignant Pleural Mesothelioma 2020 ·Molecular Therapy — Oncolytics ·(unknown), (unknown), (unknown), (unknown), (unknown), Johann Foloppe, (unknown), (unknown), Daniel Pouliquen, Marc Grégoire, Nicolas Boisgerault, Philippe Erbs, Jean‐François Fonteneau	6
8	Preclinical Evaluation of the Oncolytic Vaccinia Virus TG6002 by Translational Research on Canine Breast Cancer 2020 ·Molecular Therapy — Oncolytics ·(unknown), Johann Foloppe, Christelle Maurey, Eve Laloy, (unknown), (unknown), (unknown), (unknown), Pascale Cordier, Hélène Huet, Éric Quéméneur, Bernard Klonjkowski, Philippe Erbs	18
9	594 BT-001, an oncolytic vaccinia virus armed with a Treg-depleting human recombinant anti-CTLA4 antibody and GM-CSF to target the tumor microenvironment 2020 ·SHILAP Revista de lepidopterología ·Monika Semmrich, Jean‐Baptiste Marchand, Laetitia Fend, Matilda Rehn, Nathalie Silvestre, Linda Mårtensson, Johann Foloppe, Ingrid Teige, Éric Quéméneur, Björn Frendéus	5
10	Safety studies and viral shedding of intramuscular administration of oncolytic vaccinia virus TG6002 in healthy beagle dogs 2020 ·BMC Veterinary Research ·(unknown), (unknown), Murielle Gantzer, (unknown), Johann Foloppe, Jean‐Marc Balloul, Eve Laloy, Dominique Tierny, Bernard Klonjkowski, Éric Quéméneur, Christelle Maurey, Philippe Erbs	6
11	Abstract 5602: BT-001, an oncolytic vaccinia virus armed with a Treg-depletion-optimized recombinant human anti-CTLA4 antibody and GM-CSF to target the tumor microenvironment 2020 ·Cancer Research ·Jean‐Baptiste Marchand, Monika Semmrich, Laetitia Fend, Matilda Rehn, Nathalie Silvestre, Ingrid Teige, Johann Foloppe, Linda Mårtensson, Éric Quéméneur, Björn Frendéus	4
12	The Enhanced Tumor Specificity of TG6002, an Armed Oncolytic Vaccinia Virus Deleted in Two Genes Involved in Nucleotide Metabolism 2019 ·Molecular Therapy — Oncolytics ·Johann Foloppe, (unknown), (unknown), Jacqueline Kintz, Pascale Cordier, (unknown), Annie Findeli, (unknown), Éric Quéméneur, Philippe Erbs	72
13	Deletion of Apoptosis Inhibitor F1L in Vaccinia Virus Increases Safety and Oncolysis for Cancer Therapy 2019 ·Molecular Therapy — Oncolytics ·Adrian Pelin, Johann Foloppe, (unknown), Ragunath Singaravelu, (unknown), (unknown), Victoria A. Jennings, Lawton J. Stubbert, Madison Foster, (unknown), Antonio Postigo, (unknown), (unknown), Michael Way, Philippe Erbs, Fabrice Le Bœuf, John C. Bell	24
14	Ultrasound-mediated cavitation does not decrease the activity of small molecule, antibody or viral-based medicines 2018 ·International Journal of Nanomedicine ·Rachel Myers, (unknown), Cliff Rowe, Christian Coviello, Luca Baù, Philippe Erbs, Johann Foloppe, Jean‐Marc Balloul, (unknown), Constantin Coussios, Robert Carlisle	14
15	Vaccinia Virus Shuffling: deVV5, a Novel Chimeric Poxvirus with Improved Oncolytic Potency 2018 ·Cancers ·(unknown), Johann Foloppe, D Antoine, Annie Findeli, (unknown), Pascale Cordier, (unknown), (unknown), Monika Lusky, Éric Quéméneur, Philippe Erbs	16
16	Cowpox Virus: A New and Armed Oncolytic Poxvirus 2017 ·Molecular Therapy — Oncolytics ·(unknown), Johann Foloppe, (unknown), (unknown), D Antoine, (unknown), (unknown), Pascale Cordier, Éric Quéméneur, (unknown), Stéphane Bertagnoli, Philippe Erbs	16
17	Polymeric Cups for Cavitation-mediated Delivery of Oncolytic Vaccinia Virus 2016 ·Molecular Therapy ·Rachel Myers, Christian Coviello, Philippe Erbs, Johann Foloppe, Cliff Rowe, James Kwan, Calum Crake, Sean P. Finn, Edward Jackson, Jean‐Marc Balloul, (unknown), Constantin Coussios, Robert Carlisle	53
18	Oncolytic virotherapy with an armed vaccinia virus in an orthotopic model of renal carcinoma is associated with modification of the tumor microenvironment 2015 ·OncoImmunology ·Laetitia Fend, (unknown), Johann Foloppe, (unknown), (unknown), Luc Barraud, Nathalie Accart, Philippe Erbs, Sylvie Fournel, Xavier Préville	31
19	Targeted Chemotherapy for Head and Neck Cancer with a Chimeric Oncolytic Adenovirus Coding for Bifunctional Suicide Protein FCU1 2010 ·Clinical Cancer Research ·João D. Dias, Ilkka Liikanen, Kilian Guse, Johann Foloppe, Marta Słoniecka, Iulia Diaconu, Ville Rantanen, Minna Eriksson, Tanja Hakkarainen, Monika Lusky, Philippe Erbs, Sophie Escutenaire, Anna Kanerva, Sari Pesonen, Vincenzo Cerullo, Akseli Hemminki	36
20	Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus 2008 ·Gene Therapy ·Johann Foloppe, Jacqueline Kintz, (unknown), Annie Findeli, Pascale Cordier, Y. Schlesinger, Chantal Hoffmann, (unknown), (unknown), Philippe Erbs	83

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact